Kai Wang
About
Kai Wang has authored 126 papers that have received a total of 4.4k indexed citations.
This includes 65 papers in Molecular Biology, 29 papers in Infectious Diseases and 21 papers in Cancer Research. The topics of these papers are SARS-CoV-2 and COVID-19 Research (17 papers), Glycosylation and Glycoproteins Research (14 papers) and Ubiquitin and proteasome pathways (13 papers). Kai Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), Glycosylation and Glycoproteins Research (14 papers) and Ubiquitin and proteasome pathways (13 papers) and collaborates with scholars based in China, United States and Germany. Kai Wang's co-authors include Ni Tang, Ailong Huang, Jie Xia, Qingzhu Gao and Li Liang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Elizabeth A. Bayliss Breakdown of academic impact, for papers by Stephen A. Morse Breakdown of academic impact, for papers by Bruce B. Jarvis Breakdown of academic impact, for papers by David M. Panicek Breakdown of academic impact, for papers by Pierre Colson Breakdown of academic impact, for papers by Ralf Schindler Breakdown of academic impact, for papers by Anders Lewén Breakdown of academic impact, for papers by Mika Mänttäri